Riot Platforms, Inc. — Director's Dealing 2011

Jan 7, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2011-01-05

Reporting Person: Lundy Steve (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-05	Stock Option (Right to Buy)	$0.59	A	90000	Acquired	2021-01-05	Common Stock (90000)	Direct

Footnotes

F1: The option to purchase 90,000 shares of common stock shall become exercisable as to 33.33% of the shares on each of January 5, 2012 and January 5, 2013, and as to the remaining 33.34% of the shares on January 5, 2014.